Risk factors for antibiotic resistance and 30-day mortality among adult patients with acute leukemia and Escherichia coli bloodstream infection.

No abstract is available for this paper.

• Publication year

  2026

• Venue

  European Journal of Clinical Microbiology and Infectious Diseases

• Publication date

  2026-01-06

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10096-025-05394-0PMID 41493743
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Risk Factors and Clinical Management Strategies for Bloodstream Infections in Pediatric Hematological Malignancies

  2025cited by this paper
• Epidemiology and risk factors of Escherichia coli bloodstream infections associated with extended-spectrum beta-lactamase production: a national surveillance and data linkage study, Finland, 2018 to 2023

  2025cited by this paper
• Microbiology and predictors of mortality in haematological malignancy patients with gram-negative bacterial bloodstream infections.

  2025cited by this paper
• Rectal colonisation by Multidrug-resistant Gram-negative bacteria and subsequent bacteraemia in haematological patients.

  2025cited by this paper
• Prevalence and impact of multidrug-resistant bacteria in solid cancer patients with bloodstream infection: a 25-year trend analysis

  2024cited by this paper
• Adult acute leukemia patients with gram-negative bacteria bloodstream infection: Risk factors and outcomes of antibiotic-resistant bacteria

  2024cited by this paper
• Demographic, clinical and molecular epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli bloodstream infections in Central Australia.

  2024cited by this paper
• Epidemiology and drug resistance analysis of bloodstream infections in an intensive care unit from a children’s medical center in Eastern China for six consecutive years

  2024cited by this paper
• Antimicrobial resistance in Escherichia coli and Staphylococcus aureus at human-animal interfaces on Chongming Island, Shanghai: A One Health perspective

  2024cited by this paper
• Clinical and genomic characterization of carbapenem-resistant Enterobacterales bloodstream infections in patients with hematologic malignancies

  2024cited by this paper
• Prevalence and determinants of antimicrobial resistance of pathogens isolated from cancer patients in an intensive care unit in Alexandria, Egypt

  2023cited by this paper
• Escherichia coli ST131 Associated with Increased Mortality in Bloodstream Infections from Urinary Tract Source

  2023cited by this paper
• Clinical features of febrile neutropenia and bloodstream infection in autologous hematopoietic cell transplantation: Comparison to those in intensive chemotherapy for acute myeloid leukemia.

  2023cited by this paper
• Outcomes Associated with Empiric Cefepime for Bloodstream Infections Caused by Ceftriaxone-Resistant, Cefepime-Susceptible Escherichia coli and Klebsiella pneumoniae.

  2023cited by this paper
• Clinical Characteristics and Associated Factors for Mortality in Patients with Carbapenem-Resistant Enterobacteriaceae Bloodstream Infection

  2023cited by this paper
• Optimization of Empirical Antimicrobial Therapy in Enterobacterales Bloodstream Infection Using the Extended-Spectrum Beta-Lactamase Prediction Score

  2023cited by this paper
• Characteristics, Outcomes, and Clinical Indicators of Bloodstream Infections in Neutropenic Patients with Hematological Malignancies: A 7-Year Retrospective Study

  2023cited by this paper
• Bloodstream gram-negative bacterial infections in adult patients with leukemia: A retrospective review of medical records in a tertiary care hospital in Western Saudi Arabia.

  2023cited by this paper
• Mortality and length of hospital stay after bloodstream infections caused by ESBL-producing compared to non-ESBL-producing E. coli

  2023cited by this paper
• Increasing proportions of extended-spectrum β-lactamase-producing isolates among Escherichia coli from urine and bloodstream infections: results from a nationwide surveillance network, Finland, 2008 to 2019

  2023cited by this paper
• Evaluation of antibiotic resistance, toxin-antitoxin systems, virulence factors, biofilm-forming strength and genetic linkage of Escherichia coli strains isolated from bloodstream infections of leukemia patients

  2023cited by this paper
• Risk factors for antibiotic resistance and mortality in patients with bloodstream infection of Escherichia coli

  2022cited by this paper
• Risk Factors for Extended-Spectrum-β-Lactamase-Producing Escherichia coli in Community-Onset Bloodstream Infection: Impact on Long-Term Care Hospitals in Korea

  2021cited by this paper
• Molecular Characteristics of Escherichia coli Causing Bloodstream Infections During 2010–2015 in a Tertiary Hospital, Shanghai, China

  2021cited by this paper
• Mortality in Escherichia coli bloodstream infections: a multinational population-based cohort study

  2021cited by this paper
• A nationwide population-based study of Escherichia coli bloodstream infections: incidence, antimicrobial resistance and mortality.

  2021cited by this paper
• Bloodstream infections in adult patients with malignancy, epidemiology, microbiology, and risk factors associated with mortality and multi-drug resistance

  2021cited by this paper
• Clinical and Microbiological Characteristics of Recurrent Escherichia coli Bacteremia

  2021cited by this paper
• Mortality in Escherichia coli bloodstream infections: antibiotic resistance still does not make it.

  2020cited by this paper
• Risk Factors and Outcomes of Antibiotic-resistant Pseudomonas aeruginosa Bloodstream Infection in Adult Patients With Acute Leukemia.

  2020cited by this paper
• Epidemiology of Escherichia coli Bacteremia: A Systematic Literature Review.

  2020cited by this paper
• Inappropriate Empirical Antibiotic Treatment in High-risk Neutropenic Patients With Bacteremia in the Era of Multidrug Resistance.

  2019cited by this paper
• Association between inappropriate empirical antimicrobial therapy and hospital length of stay in Gram-negative bloodstream infections: stratification by prognosis

  2017cited by this paper
• Prevalence and risk factors of Gram-negative bacilli causing blood stream infection in patients with malignancy

  2016cited by this paper

• No citing papers are available for this paper.